NJ A3536 | 2020-2021 | Regular Session

Note: Carry Foward to future A1845
Note: Carry Over of previous A5948

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 25 2020 - 25% progression, died in committee
Action: 2020-02-25 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Pending: Assembly Financial Institutions and Insurance Committee
Text: Latest bill text (Introduced) [HTML]

Summary

Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.

Sponsors


History

DateChamberAction
2020-02-25AssemblyIntroduced, Referred to Assembly Financial Institutions and Insurance Committee

Same As/Similar To

A3536 (Carry Over) 2020-02-25 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee
A5948 (Carry Over) 2019-11-18 - Introduced, Referred to Assembly Financial Institutions and Insurance Committee

Subjects


New Jersey State Sources


Bill Comments

feedback